-
Case Reports Clinical Trial
Moclobemide in chronic neuropathic pain: preliminary case reports.
- D B Menkes, J P Fawcett, A F Busch, and D Jones.
- Department of Psychological Medicine, University of Otago, Dunedin, New Zealand.
- Clin J Pain. 1995 Jun 1; 11 (2): 134-8.
ObjectiveThis trial aimed to study moclobemide, a reversible, Type-A selective monoamine oxidase inhibitor, in patients with chronic neuropathic pain.DesignPain clinic patients suitable for antidepressant therapy were treated for 2 months in an open label, uncontrolled trial with moclobemide 150-600 mg/day.Outcome MeasuresVisual analog scores of pain and affective symptoms, a side-effect checklist, and clinical global impressions of efficacy and tolerability.ResultsThe trial was terminated after assessment of seven patients; partial analgesic activity was discernible only in one, and beneficial mood effects notable in two others. Significant adverse effects, particularly insomnia and GI disturbance, were reported by the majority of patients.ConclusionMoclobemide appears to have limited efficacy in the treatment of neuropathic pain.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..